IGF2BP2 and familial pancreatic carcinoma: Furthermore, Wu et al. evaluated the prognosis and progression of pancreatic cancer patients using a predictive model that incorporated ferroptosis regulators and m6A methyltransferases, including IGF2BP2, IGF2BP3, and METTL16 (Wu et al., 2022).